Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 4, 2026, 8:41 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 217–240 of 1,818 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Media Clear all

Conditions: Psychology, Social, Adolescent Behavior
Interventions: Gun handling behavior, Debriefing; Behavioral · Other
Lead sponsor: Ohio State University; Other
Eligibility: 8 Years to 12 Years
Enrollment: 245 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022
U.S. locations: 1
States / cities: Columbus, Ohio

Conditions: Healthy Volunteers
Interventions: Regadenoson, Placebo; Drug
Lead sponsor: Astellas Pharma Global Development, Inc.; Industry
Eligibility: 18 Years to 60 Years
Enrollment: 36 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2013
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Pediatric Cancers
Interventions: Carotid Ultrasound; Procedure
Lead sponsor: M.D. Anderson Cancer Center; Other
Eligibility: Up to 21 Years
Enrollment: 3 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2010
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Stargardt Disease, Stargardt Macular Degeneration, Stargardt Macular Dystrophy
Interventions: SB-007; Genetic
Lead sponsor: Splice Bio; Industry
Eligibility: 12 Years to 65 Years
Enrollment: 57 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2028
U.S. locations: 5
States / cities: Aurora, Colorado • Miami, Florida • Boston, Massachusetts + 2 more

Conditions: Embryonic Mosaicism, Embryo Culture Media, Embryo Morphokinetics, Infertility
Interventions: EmbryoScope Plus, GLOBAL MEDIA, SAGE MEDIA; Device · Other
Lead sponsor: University of California, San Francisco; Other
Eligibility: 18 Years to 42 Years · Female only
Enrollment: 200 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2019
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Surgery
Interventions: Control, WISEMD Original, Social Networking, Social Networking plus Emotional Design; Other
Lead sponsor: NYU Langone Health; Other
Eligibility: Not listed
Enrollment: 1,363 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2008 – 2011
U.S. locations: 7
States / cities: Augusta, Georgia • Omaha, Nebraska • Brooklyn, New York + 4 more

Conditions: Alcohol Problem, Harm Reduction, Alcohol-Related Harm
Interventions: Singularities Game, Food4Thought; Behavioral
Lead sponsor: University of Pittsburgh; Other
Eligibility: 14 Years to 18 Years
Enrollment: 28 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025
U.S. locations: 1
States / cities: Pittsburgh, Pennsylvania

Conditions: Chest Pain
Interventions: Somatom Force CT Scanner; Device
Lead sponsor: Medical University of South Carolina; Other
Eligibility: 18 Years to 85 Years
Enrollment: 2 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2015
U.S. locations: 1
States / cities: Charleston, South Carolina

Conditions: Mental Health Wellness
Interventions: GUIDE; Behavioral
Lead sponsor: University of Pennsylvania; Other
Eligibility: 18 Years and older
Enrollment: 115 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Underage Drinking
Interventions: Interactive Social Networking Site Parent Based Intervention, Active Control; Behavioral
Lead sponsor: University of North Texas Health Science Center; Other
Eligibility: 15 Years and older
Enrollment: 202 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2024
U.S. locations: 1
States / cities: Fort Worth, Texas

Conditions: Feeding Behaviors
Interventions: Varying meal energy density and portion size; Other
Lead sponsor: Penn State University; Other
Eligibility: 3 Years to 6 Years
Enrollment: 131 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: Started 2013
U.S. locations: 1
States / cities: University Park, Pennsylvania

Conditions: Obesity
Interventions: Low fat diet, High fat diet, MCT diet; Dietary Supplement
Lead sponsor: Oregon Health and Science University; Other
Eligibility: 18 Years and older
Enrollment: 51 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2008 – 2011
U.S. locations: 1
States / cities: Portland, Oregon

Conditions: Exocrine Pancreatic Insufficiency (EPI), Cystic Fibrosis (CF), Pancreatic Enzyme Abnormality, Pancreatic Diseases
Interventions: NHS7108, Zenpep®; Drug
Lead sponsor: Aimmune Nestlé Health Science US R&D, LLC; Industry
Eligibility: 18 Years to 85 Years
Enrollment: 66 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 14
States / cities: Scottsdale, Arizona • Little Rock, Arkansas • Los Angeles, California + 10 more

Conditions: Eustachian Tube Dysfunction, Chronic Otitis Media
Interventions: Not listed
Lead sponsor: University of Pittsburgh; Other
Eligibility: 18 Years to 75 Years
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2016
U.S. locations: 1
States / cities: Pittsburgh, Pennsylvania

Conditions: Thyroid Nodule, Thyroid Neoplasms, Thyroid Cancer
Interventions: Biopsy, Active Monitoring; Procedure
Lead sponsor: Dartmouth-Hitchcock Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2027
U.S. locations: 1
States / cities: Lebanon, New Hampshire

Conditions: Colorectal Cancer
Interventions: Touch 2 Screen, Touch screen intervention; Other
Lead sponsor: Allen A. Greiner, MD, MPH; Other
Eligibility: 50 Years and older
Enrollment: 470 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2007 – 2012
U.S. locations: 1
States / cities: Kansas City, Kansas

Conditions: Asthma
Interventions: Placebo twice daily, Olodaterol low daily dose twice daily, Olodaterol medium daily dose twice daily, Olodaterol high daily dose once daily and placebo, Olodaterol medium daily dose once daily and placebo; Drug
Lead sponsor: Boehringer Ingelheim; Industry
Eligibility: 18 Years to 70 Years
Enrollment: 206 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: Started 2011
U.S. locations: 12
States / cities: Huntington Beach, California • Centennial, Colorado • Wheat Ridge, Colorado + 9 more

Conditions: Intraocular Melanoma, Melanoma (Skin)
Interventions: pyrazoloacridine; Drug
Lead sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins; Other
Eligibility: 18 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: 1999 – 2002
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Cannabis, Psychotic Disorders
Interventions: THC, Placebo; Drug
Lead sponsor: Yale University; Other
Eligibility: 21 Years to 35 Years
Enrollment: 57 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2012 – 2015
U.S. locations: 1
States / cities: West Haven, Connecticut

Conditions: Wellness, Health
Interventions: Geranylgeraniol 300 mg, Placebo; Dietary Supplement
Lead sponsor: Designs for Health; Industry
Eligibility: 40 Years to 65 Years
Enrollment: 34 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025
U.S. locations: 1
States / cities: Palm Coast, Florida

Conditions: Cognitive Impairment Associated With Schizophrenia (CIAS)
Interventions: KYN-5356 low dose, Placebo, KYN-5356 Medium Dose, KYN-5356 High Dose; Drug · Other
Lead sponsor: Kynexis B.V.; Industry
Eligibility: 18 Years to 55 Years
Enrollment: 149 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2026
U.S. locations: 15
States / cities: Little Rock, Arkansas • Cerritos, California • Lemon Grove, California + 12 more

Conditions: Alzheimer Disease, Dementia, Gamification, Assistive Technology
Interventions: The MapHabit system (MHS); Device
Lead sponsor: MapHabit, Inc.; Industry
Eligibility: Not listed
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2023
U.S. locations: 1
States / cities: Atlanta, Georgia

Conditions: Uveitis; Posterior, Disorder
Interventions: DE-109 44 ug, DE-109 440 ug, DE-109 880 ug; Drug
Lead sponsor: Santen Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 592 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2016
U.S. locations: 74
States / cities: Phoenix, Arizona • Tucson, Arizona • Beverly Hills, California + 71 more

Conditions: Mesenchymal Stromal Cells, Cornea, Corneal Defect, Corneal Epithelium Defect
Interventions: MSC Secretome Eye Drops; Biological
Lead sponsor: University of Illinois Chicago; Other
Eligibility: 18 Years and older
Enrollment: 9 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024
U.S. locations: 1
States / cities: Chicago, Illinois

Search by objective public record fields.

Follow-up Gun Study: Can Safety Videos Mitigate Interest in Guns in Children?

Repeat Dose Tolerance Study of Regadenoson in Healthy Subjects

Carotid Artery Disease in Childhood Cancer Survivors

A Phase 1/2, First-in-Human Dose Escalation/Expansion Study to Evaluate the Safety, Tolerability and Preliminary Efficacy of a Subretinal Injection of SB-007 in Subjects With Stargardt Disease (STGD1)

Media, Morphokinetics, and Mosaicism

Trial of Educational Outcomes of WISE-MD

Game-Based Intervention to Reduce Alcohol-Related Harms Among Sexual and Gender Minority Youth

Myocardial Stress Perfusion Computed Tomography in the Evaluation of Patients With Acute Chest Pain Using a Novel 3rd Generation Dual-source CT System

Testing a Wellness App for First Responders, Military Personnel and Veterans

Parental Research on Interventions for Social Media

Effects of Portion Size and Energy Density of a Single Meal in Preschool Children

Ghrelin Regulation and Structure: Effect of Diet Composition on Ghrelin

A Study to Evaluate Safety and Explore Efficacy of New Lipase NHS7108 in Adult Participants With Exocrine Pancreatic Insufficiency.

Risk Factors and Potential Causes of Eustachian Tube Dysfunction in Adults

TRAIL Study: Feasibility and Pilot

"Touch 2 Screen" Multi-media Colorectal Cancer Screening Intervention

A Study to Compare the Efficacy and Safety of Different Dosings of Olodaterol Administered With the Respimat® Inhaler in Patients With Moderate to Severe Asthma

Pyrazoloacridine in Treating Patients With Metastatic Skin or Eye Melanoma

Cannabinoids and Cerebellar-Motor Functioning

A Crossover Clinical Trial Investigating the Effects of Geranylgeraniol (GG) Supplementation on Testosterone Levels in Healthy Men and Women Over an 18-week Period

A Study to Evaluate KYN-5356 in Adults With Cognitive Impairment Associated With Schizophrenia

Efficacy of Gamification in Enhancing User Engagement

Study Assessing Double-masked Uveitis Treatment

Safety of Topical Mesenchymal Stromal Cell Secretome for Ocular Surface Disease